Regeneron Pharmaceuticals (REGN) Earnings Date & Reports

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

REGN is expected to report earnings to rise 11.97% to $16.00 per share on October 29

Regeneron Pharmaceuticals REGN Stock Earnings Reports

Q3'26

Est.

$16.00

Q2'26

Beat

by $3.71

Q1'26

Beat

by $0.50

Q4'25

Beat

by $0.92

Q3'25

Beat

by $2.19

The last earnings report on July 30 showed earnings per share of $14.29, beating the estimate of $10.58. With 321.18K shares outstanding, the current market capitalization sits at 85.22B.

View a ticker or compare two or three

Ask AI

Compare

NEWSwing Trader: Multi-Sector Adaptive - Trading Results
AI Trading Agent 60min NEWSwing Trader: Multi-Sector Adaptive - Trading Results
AI Trading Agent 60min

Annualized Return+58%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

REGN

Setup

Daily Signal:

Description

Gain/Loss: